Safety and Efficacy of Tarlatamab in Patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study
Tarlatamab治疗神经内分泌性前列腺癌患者的安全性和有效性:来自1b期DeLLpro-300研究的结果
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1211
Aggarwal, Rahul; Rottey, Sylvie; Bernard-Tessier, Alice; Mellado, Begoña; Kosaka, Takeo; Stadler, Walter M; Horvath, Lisa; Greil, Richard; O'Neil, Bert; Siddiqui, Bilal A; Bauernhofer, Thomas; Bilen, Mehmet A; Eskens, Ferry; Sandhu, Shahneen; Shaw, Crystal; Ju, Chia Hsin; Decato, Benjamin E; Yu, Brian; Aparicio, Ana